NPPA issued the retail price of the myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Pharmaceuticals Ltd. (Marketer)

Dec 14, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on December 10, 2025, issued the retail price of the myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Pharmaceuticals Ltd. (Marketer).

The following has been stated:

• The retail price of the Each Film Coated Bilayered Tablet Contains: myo-Inositol IP 600 mg + Metformin Hydrochloride IP 500 mg (As sustained release) M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Emcure Pharmaceuticals Ltd. (Marketer) will be Rs. 23.59/-

• Sum of MAT value considered for price calculation (in Lakhs) - 5,989.29 

• Sum of PTR per unit considered for price calculation - 162.72

[Notification No. 19(4914)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT